03:57 PM EDT, 03/22/2024 (MT Newswires) -- Invivyd ( IVVD ) stock was up 4.5% Friday before its trading was halted to announce an emergency use authorization for its Pemgarda monoclonal antibody to prevent COVID-19 in adults and youths with moderate-to-severe immunodeficiency disorders.

The US Food and Drug Administration decision makes Pemgarda available to people 12 years or older with moderate-to-severe compromised immune systems due to a variety of factors, or who are unlikely to respond well to available COVID-19 vaccines.

Invivyd ( IVVD ) executives are slated to discuss the FDA authorization with analysts and investors soon after Friday's market close.

Price: 3.23, Change: +0.14, Percent Change: +4.53